Clearbridge Investments, LLC Prothena Corp Public LTD CO Transaction History

Clearbridge Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$8.73 - $13.74 $209 - $329	-24 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$10.99 - $44.21 $318 - $1,282	-29 Reduced 54.72%	24 $1,000
Q1 2018 May 15, 2018	BUY	$27.95 - $45.04 $810 - $1,306	29 Added 120.83%	53 $2,000
Q3 2017 Nov 14, 2017	BUY	$53.83 - $67.75 $1,291 - $1,626	24	24 $2,000

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $678M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.